Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EPS (Weighted Average and Diluted) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.69 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 43.75% to $0.69 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.52, a 30.57% increase, with the full-year FY2025 number at $2.52, up 30.57% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.69 for Q4 2025 at Lemaitre Vascular, down from $0.75 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.75 in Q3 2025 to a low of $0.16 in Q2 2022.
  • A 5-year average of $0.4 and a median of $0.37 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 135.29% in 2021, then tumbled 60.0% in 2022.
  • Lemaitre Vascular's EPS (Weighted Average and Diluted) stood at $0.28 in 2021, then dropped by 10.71% to $0.25 in 2022, then surged by 52.0% to $0.38 in 2023, then grew by 26.32% to $0.48 in 2024, then surged by 43.75% to $0.69 in 2025.
  • Per Business Quant, the three most recent readings for LMAT's EPS (Weighted Average and Diluted) are $0.69 (Q4 2025), $0.75 (Q3 2025), and $0.6 (Q2 2025).